Arkolith/Insider Trading/MBX/Form 4

Gordon Carl L

Director, 10% OwnerMBX Biosciences, Inc. (MBX) · full profile →Form 4 · filed Sep 17, 2024
Net Buying
Open-Market Buys
$12.0M
Open-Market Sells
$0
Net Open-Market Flow
$12.0M
Transactions
7
4 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 16, 2024Buy(P)500K$16.00$8.0M3.2M
Sep 16, 2024Buy(P)250K$16.00$4.0M654K
Sep 16, 2024Conversion(C)2.7M——2.7M
Sep 16, 2024Conversion(C)404K——404K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 16, 2024Conversion(C)19.6M——0
Sep 16, 2024Conversion(C)4.9M——0
Sep 16, 2024Conversion(C)12.4M——0

Transaction Codes

P
Open-market purchase
C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-107524) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML